Injectafer is now the first and only intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
The development and deployment of effective vaccines can help to mitigate the impact of pandemics, and we must prioritize research efforts to achieve this objective
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
These initiatives aim to improve access to healthcare for rare disease patients
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Subscribe To Our Newsletter & Stay Updated
